InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Can we finance our pension fund with IP assets?


My CEO saw that Diageo has added whisky to its pension fund. He is keen to explore ways of plugging our own pension funding hole with non-traditional assets such as IP. What advice do you have?

The actuary You need to think about what both the trustees of the pension plan and the company are trying to achieve. The trustees will be looking for additional security so the asset needs to have a value if there is...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Rich pickings: how Hollywood rivals will profit from Weinstein's downfall https://t.co/3v4ZamycWP Analysis of Weinstein Co IP via @guardian

Oct 20 2017 03:32 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @BakerMcK_LonIP: Read @BakerIPnewsDACH and @BakerMcK_LonIP summary in @ManagingIP on the BGH's #3D chocolate packaging decision 🍫🇩🇪🇬🇧htt…

Oct 20 2017 02:28 ·  reply ·  retweet ·  favourite
ManagingIP profile

Bea Swedlow takes over from Randi Karpinia as @WomenInIP Committee chair at #aiplaAM17 - "Randi keeps me in check + I keep her out of check!

Oct 20 2017 11:57 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements